Examples of 'elvitegravir' in a sentence
Meaning of "elvitegravir"
elvitegravir (noun) - a type of antiretroviral medication used to treat HIV infections by inhibiting the action of the viral integrase enzyme
Show more definitions
- An integrase inhibitor used to treat HIV infection.
How to use "elvitegravir" in a sentence
Basic
Advanced
elvitegravir
Vitekta contains the active substance elvitegravir.
The active substance elvitegravir is persistent in the environment.
If you are taking another protease inhibitor or elvitegravir.
No human data on the effect of elvitegravir on fertility are available.
Studies performed with ritonavir boosted elvitegravir.
Elvitegravir has a relatively low genetic barrier to resistance.
These studies were performed with ritonavir boosted elvitegravir.
Elvitegravir is primarily metabolised and eliminated by the liver.
There is no specific antidote for overdose with elvitegravir.
Cobicistat increases the level of elvitegravir by slowing its breakdown.
No interactions were studied using unboosted elvitegravir.
The pharmacokinetics of elvitegravir in paediatric subjects have not been established.
Interaction not studied with elvitegravir.
It is not known whether elvitegravir or cobicistat are excreted in human milk.
Elvitegravir is a medicine that belongs to a group called integrase inhibitors.
See also
The integrase inhibitors include elvitegravir and dolutegravir.
And elvitegravir in the presence of.
Animal studies do not indicate harmful effects of elvitegravir on fertility.
Viruses expressing elvitegravir or raltegravir resistance mutations maintain susceptibility to dolutegravir.
The active substance is elvitegravir.
Elvitegravir simultaneous administration.
There are no or limited clinical data with elvitegravir in pregnant women.
Elvitegravir are not expected to.
An improved production method and new intermediates of synthesis of elvitegravir.
Dose of elvitegravir should be.
A new production method and new intermediates of synthesis of elvitegravir.
Elvitegravir plasma concentrations.
Vitekta is an antiviral medicine that contains the active substance elvitegravir.
And elvitegravir is not.
The combination of elvitegravir.
Their conversion to elvitegravir is possible with the use of known procedures.
Combination with elvitegravir.
No dose adjustment of elvitegravir or cobicistat is necessary for patients with renal impairment.
No signal for neural tube defects associated with bictegravir or elvitegravir.
The pharmacokinetics of elvitegravir or cobicistat in paediatric subjects have not been fully established.
Further increases in ritonavir dose do not result in further increases in elvitegravir exposure.
Both elvitegravir and cobicistat are primarily metabolised and eliminated by the liver.
Concentrations of rosuvastatin are transiently increased when administered with elvitegravir and cobicistat.
Elvitegravir as a single agent is indicated only in combination with certain ritonavir boosted PIs.
Concentrations of pitavastatin may be increased when administered with elvitegravir and cobicistat.
Elvitegravir is also a component of the Quad single tablet regimen.
Vitekta should not be used in combination with products containing elvitegravir or pharmacokinetic.
Elvitegravir is currently in clinical trials for treatment of HIV infection.
No clinically relevant pharmacokinetic differences due to ethnicity have been identified for boosted elvitegravir.
Elvitegravir did not show inhibition of replication of HBV or HCV in vitro.
No clinically relevant pharmacokinetic differences due to gender have been identified for boosted elvitegravir.
Elvitegravir is also under regulatory review by the European Medicines Agency.
Concentrations of atorvastatin and pitavastatin may be increased when administered with elvitegravir and cobicistat.
Elvitegravir is a type of antiviral agent called an ‘ integrase inhibitor.
Concentrations of warfarin may be affected upon co-administration with elvitegravir.
